305 related articles for article (PubMed ID: 33921431)
1. Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test.
Arteche-López A; Gómez Rodríguez MJ; Sánchez Calvin MT; Quesada-Espinosa JF; Lezana Rosales JM; Palma Milla C; Gómez-Manjón I; Hidalgo Mayoral I; Pérez de la Fuente R; Díaz de Bustamante A; Darnaude MT; Gil-Fournier B; Ramiro León S; Ramos Gómez P; Sierra Tomillo O; Juárez Rufián A; Arranz Cano MI; Villares Alonso R; Morales-Pérez P; Segura-Tudela A; Camacho A; Nuñez N; Simón R; Moreno-García M; Alvarez-Mora MI
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921431
[TBL] [Abstract][Full Text] [Related]
2. Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: evidence supporting whole exome sequencing as first tier test.
Sheth F; Shah J; Jain D; Shah S; Patel H; Patel K; Solanki DI; Iyer AS; Menghani B; Mhatre P; Mehta S; Bajaj S; Patel V; Pandya M; Dhami D; Patel D; Sheth J; Sheth H
BMC Neurol; 2023 Aug; 23(1):292. PubMed ID: 37543562
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genetic analysis of children with unexplained neurodevelopmental delay and neurodevelopmental comorbidities in a Chinese cohort using trio-based whole-exome sequencing.
Wu R; Li X; Meng Z; Li P; He Z; Liang L
Orphanet J Rare Dis; 2024 May; 19(1):205. PubMed ID: 38764027
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.
Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal microarray and whole-exome sequence analysis in Taiwanese patients with autism spectrum disorder.
Chang YS; Lin CY; Huang HY; Chang JG; Kuo HT
Mol Genet Genomic Med; 2019 Dec; 7(12):e996. PubMed ID: 31595719
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic yield of next-generation sequencing in 87 families with neurodevelopmental disorders.
Álvarez-Mora MI; Sánchez A; Rodríguez-Revenga L; Corominas J; Rabionet R; Puig S; Madrigal I
Orphanet J Rare Dis; 2022 Feb; 17(1):60. PubMed ID: 35183220
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
Yuen T; Carter MT; Szatmari P; Ungar WJ
Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
[TBL] [Abstract][Full Text] [Related]
9. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
Shin S; Yu N; Choi JR; Jeong S; Lee KA
Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
Srivastava S; Love-Nichols JA; Dies KA; Ledbetter DH; Martin CL; Chung WK; Firth HV; Frazier T; Hansen RL; Prock L; Brunner H; Hoang N; Scherer SW; Sahin M; Miller DT;
Genet Med; 2019 Nov; 21(11):2413-2421. PubMed ID: 31182824
[TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
Tammimies K; Marshall CR; Walker S; Kaur G; Thiruvahindrapuram B; Lionel AC; Yuen RK; Uddin M; Roberts W; Weksberg R; Woodbury-Smith M; Zwaigenbaum L; Anagnostou E; Wang Z; Wei J; Howe JL; Gazzellone MJ; Lau L; Sung WW; Whitten K; Vardy C; Crosbie V; Tsang B; D'Abate L; Tong WW; Luscombe S; Doyle T; Carter MT; Szatmari P; Stuckless S; Merico D; Stavropoulos DJ; Scherer SW; Fernandez BA
JAMA; 2015 Sep; 314(9):895-903. PubMed ID: 26325558
[TBL] [Abstract][Full Text] [Related]
12. Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach.
Fernandez BA; Scherer SW
Dialogues Clin Neurosci; 2017 Dec; 19(4):353-371. PubMed ID: 29398931
[TBL] [Abstract][Full Text] [Related]
13. A Next Generation Sequencing-Based Protocol for Screening of Variants of Concern in Autism Spectrum Disorder.
Huang J; Liu J; Tian R; Liu K; Zhuang P; Sherman HT; Budjan C; Fong M; Jeong MS; Kong XJ
Cells; 2021 Dec; 11(1):. PubMed ID: 35011571
[TBL] [Abstract][Full Text] [Related]
14. Whole Exome Sequencing Identifies Novel De Novo Variants Interacting with Six Gene Networks in Autism Spectrum Disorder.
Kim N; Kim KH; Lim WJ; Kim J; Kim SA; Yoo HJ
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374967
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Diagnostic Exome Sequencing in Patients With Diagnosed or Suspected Autism Spectrum Disorders.
Rossi M; El-Khechen D; Black MH; Farwell Hagman KD; Tang S; Powis Z
Pediatr Neurol; 2017 May; 70():34-43.e2. PubMed ID: 28330790
[TBL] [Abstract][Full Text] [Related]
16. Impact of on-site clinical genetics consultations on diagnostic rate in children and young adults with autism spectrum disorder.
Munnich A; Demily C; Frugère L; Duwime C; Malan V; Barcia G; Vidal C; Throo E; Besmond C; Hubert L; Roland-Manuel G; Malen JP; Ferreri M; Hanein S; Thalabard JC; Boddaert N; Assouline M
Mol Autism; 2019; 10():33. PubMed ID: 31406558
[TBL] [Abstract][Full Text] [Related]
17. Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices.
Peabody J; Martin M; DeMaria L; Florentino J; Paculdo D; Paul M; Vanzo R; Wassman ER; Burgon T
PLoS One; 2016; 11(12):e0169064. PubMed ID: 28036350
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
[TBL] [Abstract][Full Text] [Related]
20. A semiautomated whole-exome sequencing workflow leads to increased diagnostic yield and identification of novel candidate variants.
Ji J; Shen L; Bootwalla M; Quindipan C; Tatarinova T; Maglinte DT; Buckley J; Raca G; Saitta SC; Biegel JA; Gai X
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30755392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
